Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives
KM Waldhauser, M Török, HR Ha, U Thomet… - Journal of pharmacology …, 2006 - ASPET
The aim of this work was to compare hepatocellular toxicity and pharmacological activity of
amiodarone (2-n-butyl-3-[3, 5 diiodo-4-diethylaminoethoxybenzoyl]-benzofuran; B2-O-Et-N …
amiodarone (2-n-butyl-3-[3, 5 diiodo-4-diethylaminoethoxybenzoyl]-benzofuran; B2-O-Et-N …
Amiodarone pulmonary toxicity: a patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse
K Okayasu, Y Takeda, J Kojima, A Yoshizawa… - Internal …, 2006 - jstage.jst.go.jp
A 44-year-old man was treated with amiodarone for dilated cardiomyopathy. After 53
months, he developed amiodarone-induced interstitial pneumonia. Amiodarone treatment …
months, he developed amiodarone-induced interstitial pneumonia. Amiodarone treatment …
Fatal hepatotoxicity following oral administration of amiodarone
M Richer, S Robert - Annals of Pharmacotherapy, 1995 - journals.sagepub.com
Objetivo: Informar un caso de hepatotoxicidad fatal asociado al uso crónico de amiodarona
oral. Resumen Del Caso: En 1992 un paciente de 64 años requirió el uso de amiodarona …
oral. Resumen Del Caso: En 1992 un paciente de 64 años requirió el uso de amiodarona …